Stay updated with breaking news from Treatment Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
China's domestically developed monoclonal neutralizing antibody therapy for COVID-19 treatment could be used clinically in the country within weeks after it was included in the country's Diagnosis and Treatment Protocol for COVID-19－adding a tool to the global arsenal against the coronavirus.
China's domestically developed monoclonal neutralizing antibody therapy for COVID-19 treatment could be used clinically in the country within weeks.
/PRNewswire/ -- Asclepius Meditec ("the Company"), the organizer of the conference, is pleased to announce that five academicians of the Chinese Academy of...
SHANGHAI, Nov. 27, 2021 /PRNewswire/ -- Asclepius Meditec ("the Company"), the organizer of the conference, is pleased to announce that five academicians of the Chinese Academy of Engineering
/PRNewswire/ -- Asclepius Meditec ("the Company"), the organizer of the conference, is pleased to announce that five academicians of the Chinese Academy of...